Patient characteristics
| . | All patients (n = 306) . | CART ineligible (n = 124) . | CART infused (n = 182) . | P value . |
|---|---|---|---|---|
| Median age (IQR), y | 61 (53-68) | 61 (53-68) | 60 (52-67) | .55 |
| Sex, n (%) | ||||
| Male | 200 (65%) | 84 (68%) | 116 (64%) | .54 |
| Female | 106 (35%) | 40 (32%) | 66 (36%) | |
| Race, n (%) | ||||
| White | 234 (76%) | 95 (77%) | 139 (77%) | .99 |
| Other/unspecified | 48 (16%) | 19 (15%) | 29 (16%) | |
| Asian | 14 (4%) | 6 (5%) | 8 (4%) | |
| Black | 10 (3%) | 4 (3%) | 6 (3%) | |
| Ethnicity, n (%) | .21 | |||
| Non-Hispanic | 210 (69%) | 80 (65%) | 130 (71%) | |
| Hispanic/Latino | 57 (19%) | 28 (23%) | 29 (16%) | |
| Unspecified/other | 39 (13%) | 16 (13%) | 23 (13%) | |
| Consultation year | .001∗ | |||
| 2018 | 11 (4%) | 10 (8%) | 16 (9%) | |
| 2019 | 42 (14%) | 23 (19%) | 31 (17%) | |
| 2020 | 56 (18%) | 25 (20%) | 32 (18%) | |
| 2021 | 80 (26%) | 31 (25%) | 50 (27%) | |
| 2022 | 117 (38%) | 35 (28%) | 53 (29%) | |
| NHL subtype | .8 | |||
| Diffuse large B cell | 212 (69%) | 90 (73%) | 125 (69%) | |
| Follicular | 39 (13%) | 11 (9%) | 14 (8%) | |
| Follicular/large | 22 (7%) | 0 | 9 (5%) | |
| Mantle cell | 12 (4%) | 17 (14%) | 22 (12%) | |
| Other B cell | 21 (7%) | 6 (5%) | 12 (6%) | |
| Primary insurance | .61 | |||
| Private | 187 (61%) | 74 (60%) | 113 (62%) | |
| Medicare | 89 (29%) | 31 (25%) | 58 (32%) | |
| Medicaid | 7 (2%) | 3 (2%) | 4 (2%) | |
| Other | 12 (4%) | 5 (4%) | 7 (4%) | |
| Unspecified | 11 (4%) | 11 (9%) | 0 | |
| ADI state (IQR) | 4 (2.0-7.0) | 4 (2.0-7.25) | 3 (2.0-6.0) | .12 |
| ADI national (IQR) | 43 (24.0-65.0) | 51 (28.75-73.5) | 37 (23.0-60.5) | .01† |
| Facility distance (IQR), km | 35 (17.25-140.0) | 37 (19.02-111.5) | 33 (16.59-161.7) | .93 |
| . | All patients (n = 306) . | CART ineligible (n = 124) . | CART infused (n = 182) . | P value . |
|---|---|---|---|---|
| Median age (IQR), y | 61 (53-68) | 61 (53-68) | 60 (52-67) | .55 |
| Sex, n (%) | ||||
| Male | 200 (65%) | 84 (68%) | 116 (64%) | .54 |
| Female | 106 (35%) | 40 (32%) | 66 (36%) | |
| Race, n (%) | ||||
| White | 234 (76%) | 95 (77%) | 139 (77%) | .99 |
| Other/unspecified | 48 (16%) | 19 (15%) | 29 (16%) | |
| Asian | 14 (4%) | 6 (5%) | 8 (4%) | |
| Black | 10 (3%) | 4 (3%) | 6 (3%) | |
| Ethnicity, n (%) | .21 | |||
| Non-Hispanic | 210 (69%) | 80 (65%) | 130 (71%) | |
| Hispanic/Latino | 57 (19%) | 28 (23%) | 29 (16%) | |
| Unspecified/other | 39 (13%) | 16 (13%) | 23 (13%) | |
| Consultation year | .001∗ | |||
| 2018 | 11 (4%) | 10 (8%) | 16 (9%) | |
| 2019 | 42 (14%) | 23 (19%) | 31 (17%) | |
| 2020 | 56 (18%) | 25 (20%) | 32 (18%) | |
| 2021 | 80 (26%) | 31 (25%) | 50 (27%) | |
| 2022 | 117 (38%) | 35 (28%) | 53 (29%) | |
| NHL subtype | .8 | |||
| Diffuse large B cell | 212 (69%) | 90 (73%) | 125 (69%) | |
| Follicular | 39 (13%) | 11 (9%) | 14 (8%) | |
| Follicular/large | 22 (7%) | 0 | 9 (5%) | |
| Mantle cell | 12 (4%) | 17 (14%) | 22 (12%) | |
| Other B cell | 21 (7%) | 6 (5%) | 12 (6%) | |
| Primary insurance | .61 | |||
| Private | 187 (61%) | 74 (60%) | 113 (62%) | |
| Medicare | 89 (29%) | 31 (25%) | 58 (32%) | |
| Medicaid | 7 (2%) | 3 (2%) | 4 (2%) | |
| Other | 12 (4%) | 5 (4%) | 7 (4%) | |
| Unspecified | 11 (4%) | 11 (9%) | 0 | |
| ADI state (IQR) | 4 (2.0-7.0) | 4 (2.0-7.25) | 3 (2.0-6.0) | .12 |
| ADI national (IQR) | 43 (24.0-65.0) | 51 (28.75-73.5) | 37 (23.0-60.5) | .01† |
| Facility distance (IQR), km | 35 (17.25-140.0) | 37 (19.02-111.5) | 33 (16.59-161.7) | .93 |